Our previous [7] and the present studies have demonstrated that the genetic polymorphism of human CD72 associated with susceptibility to SLE regulates the efficiency of alternative splicing, although how the polymorphism affects alternative splicing is not known. The gene discussed is CD72; the disease is systemic lupus erythematosus.